Active uptake of [18F]F-FAPI-42 in eosinophilic gastrointestinal disorder

Zhang M, Li Y. Eosinophilic gastroenteritis: a state-of-the-art review. J Gastroenterol Hepatol. 2017;32(1):64–72. https://doi.org/10.1111/jgh.13463.

Article  PubMed  Google Scholar 

Lindner T, Loktev A, Altmann A, Giesel F, Kratochwil C, Debus J, et al. Development of quinoline-based theranostic ligands for the targeting of fibroblast activation protein. J Nucl Med. 2018;59:1415–22. https://doi.org/10.2967/jnumed.118.210443.

Article  CAS  PubMed  Google Scholar 

Luo Y, Pan Q, Yang H, Peng L, Zhang W, Li F. Fibroblast activation protein-targeted PET/CT with 68Ga-FAPI for imaging IgG4-related disease: comparison to 18F-FDG PET/CT. J Nucl Med. 2021;62(2):266–71. https://doi.org/10.2967/jnumed.120.244723.

Article  CAS  PubMed  Google Scholar 

Luo Y, Pan Q, Xu H, Zhang R, Li J, Li F. Active uptake of 68Ga-FAPI in Crohn’s disease but not in ulcerative colitis. Eur J Nucl Med Mol Imaging. 2021;48(5):1682–3. https://doi.org/10.1007/s00259-020-05129-7.

Article  PubMed  Google Scholar 

Kuwert T, Schmidkonz C, Prante O, Schett G, Ramming A. FAPI PET opens a new window to understanding immune-mediated inflammatory diseases. J Nucl Med. 2022;63(8):1136–7. https://doi.org/10.2967/jnumed.122.263922.

Article  PubMed  Google Scholar 

留言 (0)

沒有登入
gif